Compounds > dansylarginine n-(3-ethyl-1,5-pentanediyl)amide
Page last updated: 2024-09-03

dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and fibrinopeptide b

dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with fibrinopeptide b in 1 studies

Compound Research Comparison

Studies
(dansylarginine n-(3-ethyl-1,5-pentanediyl)amide)		Trials
(dansylarginine n-(3-ethyl-1,5-pentanediyl)amide)		Recent Studies (post-2010)
(dansylarginine n-(3-ethyl-1,5-pentanediyl)amide)		Studies
(fibrinopeptide b)		Trials
(fibrinopeptide b)		Recent Studies (post-2010) (fibrinopeptide b)
3200445517

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boissel, JP; Elion, J; Jandrot-Perrus, M; Josso, F; Rabiet, MJ1

Other Studies

1 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and fibrinopeptide b

ArticleYear
Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin.
    Blood, 1984, Volume: 63, Issue:4

    Topics: Antithrombin III; Arginine; Blood Coagulation; Dansyl Compounds; Enzyme Activation; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Hypoprothrombinemias; Kinetics; Platelet Aggregation; Prothrombin; Thrombin

1984